Free Trial

Jaguar Animal Health (JAGX) Competitors

Jaguar Animal Health logo
$4.64 -0.15 (-3.13%)
Closing price 10/12/2026 04:00 PM Eastern
Extended Trading
$4.52 -0.12 (-2.59%)
As of 04:20 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

JAGX vs. OBSV, CURX, ENSC, CNSP, and ACXP

Should you buy Jaguar Animal Health stock or one of its competitors? Jaguar Animal Health's main competitors and comparable companies include ObsEva (OBSV), Curanex Pharmaceuticals (CURX), Ensysce Biosciences (ENSC), CNS Pharmaceuticals (CNSP), and Acurx Pharmaceuticals (ACXP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Jaguar Animal Health compare to ObsEva?

Jaguar Animal Health (NASDAQ:JAGX) and ObsEva (NASDAQ:OBSV) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

In the previous week, Jaguar Animal Health had 8 more articles in the media than ObsEva. MarketBeat recorded 8 mentions for Jaguar Animal Health and 0 mentions for ObsEva. Jaguar Animal Health's average media sentiment score of 0.30 beat ObsEva's score of 0.00 indicating that Jaguar Animal Health is being referred to more favorably in the media.

Company Overall Sentiment
Jaguar Animal Health Neutral
ObsEva Neutral

Jaguar Animal Health has a beta of -0.11, indicating that its share price is 111% less volatile than the broader market. Comparatively, ObsEva has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market.

Given ObsEva's higher possible upside, analysts plainly believe ObsEva is more favorable than Jaguar Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jaguar Animal Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
ObsEva
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

ObsEva has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat ObsEva's return on equity.

Company Net Margins Return on Equity Return on Assets
Jaguar Animal Health-187.88% N/A -131.45%
ObsEva N/A -416.36%-92.01%

Jaguar Animal Health has higher revenue and earnings than ObsEva. Jaguar Animal Health is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jaguar Animal Health$11.51M0.14-$53.43M-$3.73 thousandN/A
ObsEvaN/AN/A-$58.38M-$0.92N/A

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 17.5% of ObsEva shares are held by institutional investors. 0.1% of Jaguar Animal Health shares are held by insiders. Comparatively, 14.4% of ObsEva shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

ObsEva beats Jaguar Animal Health on 8 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to Curanex Pharmaceuticals?

Jaguar Animal Health (NASDAQ:JAGX) and Curanex Pharmaceuticals (NASDAQ:CURX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

In the previous week, Jaguar Animal Health had 7 more articles in the media than Curanex Pharmaceuticals. MarketBeat recorded 8 mentions for Jaguar Animal Health and 1 mentions for Curanex Pharmaceuticals. Curanex Pharmaceuticals' average media sentiment score of 1.79 beat Jaguar Animal Health's score of 0.30 indicating that Curanex Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Jaguar Animal Health Neutral
Curanex Pharmaceuticals Very Positive

Curanex Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health. Curanex Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jaguar Animal Health$11.51M0.14-$53.43M-$3.73 thousandN/A
Curanex PharmaceuticalsN/AN/A-$4.22M-$7.80N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jaguar Animal Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Curanex Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

12.0% of Jaguar Animal Health shares are owned by institutional investors. 0.1% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 39.7% of Curanex Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Jaguar Animal Health has a beta of -0.11, indicating that its stock price is 111% less volatile than the broader market. Comparatively, Curanex Pharmaceuticals has a beta of -2.88, indicating that its stock price is 388% less volatile than the broader market.

Curanex Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Curanex Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Jaguar Animal Health-187.88% N/A -131.45%
Curanex Pharmaceuticals N/A -82.07%-79.65%

Summary

Jaguar Animal Health and Curanex Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Ensysce Biosciences?

Ensysce Biosciences (NASDAQ:ENSC) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

Ensysce Biosciences has higher earnings, but lower revenue than Jaguar Animal Health. Ensysce Biosciences is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ensysce BiosciencesN/AN/A-$10.18M-$2.76N/A
Jaguar Animal Health$11.51M0.14-$53.43M-$3.73 thousandN/A

Ensysce Biosciences has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.Comparatively, Jaguar Animal Health has a beta of -0.11, indicating that its share price is 111% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ensysce Biosciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Jaguar Animal Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

5.6% of Ensysce Biosciences shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 2.8% of Ensysce Biosciences shares are held by company insiders. Comparatively, 0.1% of Jaguar Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Jaguar Animal Health has a net margin of -187.88% compared to Ensysce Biosciences' net margin of -280.53%. Jaguar Animal Health's return on equity of 0.00% beat Ensysce Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Ensysce Biosciences-280.53% -2,550.30% -320.49%
Jaguar Animal Health -187.88%N/A -131.45%

In the previous week, Jaguar Animal Health had 7 more articles in the media than Ensysce Biosciences. MarketBeat recorded 8 mentions for Jaguar Animal Health and 1 mentions for Ensysce Biosciences. Ensysce Biosciences' average media sentiment score of 1.79 beat Jaguar Animal Health's score of 0.30 indicating that Ensysce Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Ensysce Biosciences Very Positive
Jaguar Animal Health Neutral

Summary

Jaguar Animal Health beats Ensysce Biosciences on 7 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

Jaguar Animal Health (NASDAQ:JAGX) and CNS Pharmaceuticals (NASDAQ:CNSP) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

In the previous week, Jaguar Animal Health had 6 more articles in the media than CNS Pharmaceuticals. MarketBeat recorded 8 mentions for Jaguar Animal Health and 2 mentions for CNS Pharmaceuticals. CNS Pharmaceuticals' average media sentiment score of 1.39 beat Jaguar Animal Health's score of 0.30 indicating that CNS Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Jaguar Animal Health Neutral
CNS Pharmaceuticals Positive

Jaguar Animal Health has a beta of -0.11, meaning that its share price is 111% less volatile than the broader market. Comparatively, CNS Pharmaceuticals has a beta of 3.1, meaning that its share price is 210% more volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jaguar Animal Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
CNS Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

CNS Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health. CNS Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jaguar Animal Health$11.51M0.14-$53.43M-$3.73 thousandN/A
CNS PharmaceuticalsN/AN/A-$15.85M-$23.59N/A

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 14.0% of CNS Pharmaceuticals shares are owned by institutional investors. 0.1% of Jaguar Animal Health shares are owned by insiders. Comparatively, 1.8% of CNS Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CNS Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat CNS Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Jaguar Animal Health-187.88% N/A -131.45%
CNS Pharmaceuticals N/A -204.25%-141.87%

Summary

CNS Pharmaceuticals beats Jaguar Animal Health on 7 of the 12 factors compared between the two stocks.

How does Jaguar Animal Health compare to Acurx Pharmaceuticals?

Acurx Pharmaceuticals (NASDAQ:ACXP) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acurx Pharmaceuticals
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Jaguar Animal Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Acurx Pharmaceuticals has a beta of -2.05, meaning that its stock price is 305% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.11, meaning that its stock price is 111% less volatile than the broader market.

11.5% of Acurx Pharmaceuticals shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 6.5% of Acurx Pharmaceuticals shares are owned by company insiders. Comparatively, 0.1% of Jaguar Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Acurx Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. Acurx Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acurx PharmaceuticalsN/AN/A-$7.97M-$2.69N/A
Jaguar Animal Health$11.51M0.14-$53.43M-$3.73 thousandN/A

Acurx Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -187.88%. Jaguar Animal Health's return on equity of 0.00% beat Acurx Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Acurx PharmaceuticalsN/A -124.73% -87.48%
Jaguar Animal Health -187.88%N/A -131.45%

In the previous week, Jaguar Animal Health had 7 more articles in the media than Acurx Pharmaceuticals. MarketBeat recorded 8 mentions for Jaguar Animal Health and 1 mentions for Acurx Pharmaceuticals. Acurx Pharmaceuticals' average media sentiment score of 0.91 beat Jaguar Animal Health's score of 0.30 indicating that Acurx Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Acurx Pharmaceuticals Positive
Jaguar Animal Health Neutral

Summary

Acurx Pharmaceuticals beats Jaguar Animal Health on 8 of the 14 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAGX vs. The Competition

MetricJaguar Animal HealthPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.65M$12.44B$7.27B$13.27B
Dividend YieldN/A2.63%2.52%20.72%
P/E Ratio0.00800.11275.3725.82
Price / Sales0.14752.55582.0491.60
Price / CashN/A15.2827.3036.12
Price / Book0.008.9610.736.10
Net Income-$53.43M$2.83B$3.50B$380.59M
7 Day Performance-17.44%-1.78%-1.28%-2.03%
1 Month Performance-1.49%-4.71%-4.88%-4.22%
1 Year Performance-99.59%-4.92%5.66%-1.55%

Jaguar Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JAGX
Jaguar Animal Health
0.5448 of 5 stars
$4.64
-3.1%
N/A-99.6%$1.65M$11.51MN/A47
OBSV
ObsEva
N/AN/AN/AN/A$7.94MN/AN/A50
CURX
Curanex Pharmaceuticals
0.6434 of 5 stars
$4.97
-1.2%
N/A-65.1%$7.90MN/AN/A6
ENSC
Ensysce Biosciences
1.6154 of 5 stars
$0.42
+4.0%
N/A-75.3%$7.80M$5.07MN/A10
CNSP
CNS Pharmaceuticals
1.0744 of 5 stars
$5.07
-0.7%
N/A-46.5%$7.47MN/AN/A8

Related Companies and Tools


This page (NASDAQ:JAGX) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners